Pituitary hormone deficiency

Gene: GLI3

Green List (high evidence)

GLI3 (GLI family zinc finger 3)
EnsemblGeneIds (GRCh38): ENSG00000106571
EnsemblGeneIds (GRCh37): ENSG00000106571
OMIM: 165240, ClinGen, DECIPHER
GLI3 is in 24 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Pallister-Hall syndrome is a pleiotropic autosomal dominant disorder comprising hypothalamic hamartoma, pituitary dysfunction, central polydactyly, and visceral malformations. Short stature is a feature.

Well established gene-disease association.
Created: 28 Aug 2021, 8:16 p.m. | Last Modified: 28 Aug 2021, 8:16 p.m.
Panel Version: 0.325

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Pallister-Hall syndrome, MIM# 146510

Publications

History Filter Activity

11 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: gli3 has been classified as Green List (High Evidence).

11 Dec 2025, Gel status: 3

Set publications

Chirag Patel (Genetic Health Queensland)

Publications for gene: GLI3 were set to 24736735; 15739154

13 Jul 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Seb Lunke (Victorian Clinical Genetics Services)

gene: GLI3 was added gene: GLI3 was added to Pituitary hormone deficiency. Sources: Genomics England PanelApp,Expert Review Green Mode of inheritance for gene: GLI3 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: GLI3 were set to 24736735; 15739154 Phenotypes for gene: GLI3 were set to Greig cephalopolysyndactyly syndrome (175700); Pallister-Hall syndrome (146510)